未登录

K

Katrin Milger

ludwig-maximilians-university of munich

H指数:35

被引数:5,001

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influence of newly initiated biologic therapy on the dose of ICS therapy - Data from the German Asthma Net

新生物制剂疗法对吸入性糖皮质激素疗法剂量的影响——德国哮喘网数据

Journal of Allergy and Clinical Immunology-In Practice

IF6.6

2026-09-230

PRE

Relationship between knowledge, adherence-related behaviors and self-management with response to monoclonal antibody therapy in patients with severe asthma

严重哮喘患者中，知识、依从性行为和自我管理与单克隆抗体治疗反应之间的关系

Scientific Reports

IF3.9

2026-07-310

OA

Clinical phenotyping improves choices of biologics in asthma

临床表型分型改善了哮喘中生物制剂的选择

IF88.5

2026-04-020

PRE

Assessing health-related quality of life in patients with interstitial lung diseases with and without lung transplantation using the GR-Scale

BMC Pulmonary Medicine

IF2.8

2026-01-100

OAAI

Treatment Algorithm of Pulmonary Arterial Hypertension

肺动脉高压治疗方案

IF0

2025-10-011

PRE

“Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma”

“Tezepelumab治疗下的临床与生物缓解：重度未控制哮喘的真实世界反应”

IF12

2025-08-040

PRE

Current Blood Eosinophilia Does Not Predict the Presence of Pulmonary Hypertension in Patients with End-Stage Lung Disease

目前的血液嗜酸性粒细胞增多不能预测终末期肺病患者是否存在肺动脉高压

JOURNAL OF CLINICAL MEDICINE

IF2.9

2025-02-090

OAAI

Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019

JOURNAL OF ASTHMA AND ALLERGY

IF3

2024-11-011

OAAI

Relationship between knowledge, adherence and self-management with response to monoclonal antibody therapy in patients with severe asthma

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

The pleural microbiome in lung transplant recipients and non-transplant patients

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Impact of comorbidities on baseline characteristics in severe asthmatics in the German Asthma Net (GAN)

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Baseline characteristics of patients with severe eosinophilic asthma treated with benralizumab who reduced to anti-inflammatory reliever only vs high-, medium- or low- dose inhaled corticosteroid/formoterol: SHAMAL post-hoc analysis

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Characterization of baseline lung allograft dysfunction in single lung transplant recipients

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Decreased Number of Uncontrolled Severe Asthma Patients while Need of OCS Reduction Remains: RWE Data Analysis in Germany 2022 vs 2019

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

The Diagnosis and Treatment of Chronic Rhinosinusitis

DEUTSCHES ARZTEBLATT INTERNATIONAL

IF7.1

2024-09-200

PRE

Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany

德国严重哮喘患者Tezepelumab的真实数据

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2024-09-0110

PRE

Role of Long-Acting Bronchodilators in Patients with Clinical Asthma Remission

长效支气管扩张剂在临床哮喘缓解期患者中的作用

IF3.8

2024-08-060

OA

German asthma net: Nasal polyposis in patients in the severe asthma registry

IF12

2024-06-120

OAAI

Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with

JOURNAL OF ASTHMA AND ALLERGY

IF3

2024-06-011

OAAI

The role of coronary artery disease in lung transplantation: a propensity-matched analysis

CLINICAL RESEARCH IN CARDIOLOGY

IF3.7

2024-04-081

OAAI

Luesebrink, Enzo; Gade, Nils; Seifert, Paula; Ceelen, Felix; Veit, Tobias; Fohrer, Fabian; Hoffmann, Sabine; Hoepler, Julia; Binzenhoefer, Leonhard; Roden, Daniel; Saleh, Inas; Lanz, Hugo; Michel, Sebastian; Schneider, Christian; Irlbeck, Michael; Tomasi, Roland; Hatz, Rudolf; Hausleiter, Joerg; Hagl, Christian; Magnussen, Christina; Meder, Benjamin; Zimmer, Sebastian; Luedike, Peter; Schaefer, Andreas; Orban, Martin; Milger, Katrin; Behr, Juergen; Massberg, Steffen; Kneidinger, Nikolaus